FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Boston, Massachusetts

Biotech investors in Boston, Massachusetts

Updated 16 Nov 2026

Reset

Venture funds

1 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 MassVentures
MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy.
Boston, United States
Health care, Hardware Seed, Early stage venture, Late stage venture 26% 2

Table 1. Biotech investors in Boston, Massachusetts: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Boston, Massachusetts
One-time CSV
  • 33 firms, 33 with a website
  • 22 firm email addresses
  • 17 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-boston-massachusetts.csv33 rows × 15 columns
InvestorTypeLocationEmailPhone
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
MassChallengeStartup acceleratorBoston, United States•••@masschallenge.org
Polaris PartnersPrivate equity firmBoston, United States•••@polarispartners.com+1 855•••
Omega FundsSecondary purchaserBoston, United States•••@omegafunds.net
MPM CapitalPrivate equity firmBoston, United States•••@mpmcapital.com+1 617•••
Wellington ManagementPrivate equity firmBoston, United States•••@wellington.com617-95•••
SV Health InvestorsPrivate equity firmBoston, United States•••@svlsa.com+1 617•••
Bain Capital Life SciencesPrivate equity firmBoston, United States•••@baincapital.com

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-sector-biotech-boston-massachusetts-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
Polaris PartnersJ••• F•••Founding Partnerj•••@polarispartners.comIn the CSV
MPM CapitalC••• B••• M•••Co Managing Partnerc•••@mpmcapital.comIn the CSV
Wellington ManagementJ••• H•••CEO, Managing Partner, and Portfolio Managerj•••@wellington.comIn the CSV
SV Health InvestorsK••• B•••Managing Partnerk•••@svhealthinvestors.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

33
Investors
22
With email
17
With phone
24
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Boston, Massachusetts

30 of 33, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
2 MassChallenge Startup accelerator Boston, United States Artificial intelligence, Health care HELIOS, DrizzleX, ScribeUp 26 3,225 1,037 267 •••@masschallenge.org In the CSV
3 Polaris Partners Private equity firm, Venture capital firm Boston, United States Health care, Artificial intelligence Faro AI, Triveni Bio, Whisker Labs 3 754 215 207 •••@polarispartners.com +1 855••• In the CSV
4 Fidelity Investment bank Boston, United States Health care, Hardware Zipline International, Tenstorrent, SiMa.ai 7 586 178 285 +1-866••• In the CSV
5 Cormorant Asset Management Hedge fund Boston, United States Health care, Biotech Triveni Bio, Third Arc Bio, BlossomHill Therapeutics 4 276 58 141 In the CSV
6 Omega Funds Secondary purchaser, Venture capital firm Boston, United States Biotech, Health care FoRx Therapeutics 1 161 37 75 •••@omegafunds.net In the CSV
7 MPM Capital Private equity firm, Venture capital firm Boston, United States Biotech, Health care Reunion Neuroscience, Umoja Biopharma, āshibio 301 97 105 •••@mpmcapital.com +1 617••• In the CSV
8 Wellington Management Private equity firm, Venture capital firm Boston, United States Fintech, Health care Tabby, Current, Element Biosciences 4 335 111 160 •••@wellington.com 617-95••• In the CSV
9 SV Health Investors Private equity firm, Venture capital firm Boston, United States Health care, Biotech Alchemab Therapeutics 1 325 76 95 •••@svlsa.com +1 617••• In the CSV
10 Bain Capital Life Sciences Private equity firm, Venture capital firm Boston, United States Biotech, Health care CereVasc 1 117 41 60 •••@baincapital.com
11 Third Rock Ventures Venture capital firm Boston, United States Biotech, Health care Terremoto Biosciences 1 154 69 44 •••@thirdrockventures.com (415) ••• In the CSV
12 Half Court Ventures Venture capital firm Boston, United States Artificial intelligence, Hardware Light Frame, Flow Labs, Beacon Biosignals 4 89 1 17 In the CSV
13 Taihill Venture Venture capital firm Boston, United States Biotech, Artificial intelligence Kano Therapeutics, Bot Auto, LeyLine 65 2 4 •••@taihill.vc In the CSV
14 MassVentures Venture capital firm Boston, United States Health care, Hardware Emvolon, ZwitterCo, Kytopen 6 476 122 83 •••@mass-ventures.com +1 617••• In the CSV
15 Pillar VC Venture capital firm Boston, United States Artificial intelligence, Health care Addis Energy, OpenHands 2 149 26 18 •••@pillar.vc 857-40••• In the CSV
16 PharmStars Startup accelerator Boston, United States Health care, Artificial intelligence Triomics, Medra AI 2 68 62 4 In the CSV
17 Vida Ventures Venture capital firm Boston, United States Biotech, Health care InduPro 1 67 23 25 •••@vidaventures.com 857-25••• In the CSV
18 Innospark Ventures Venture capital firm Boston, United States Artificial intelligence, Biotech VODA.ai, Persist AI, VideaHealth 56 18 5 In the CSV
19 Broadview Ventures Venture capital firm Boston, United States Health care, Biotech CroíValve 1 75 19 12 •••@broadviewventures.org 617-34••• In the CSV
20 Longwood Fund Venture capital firm Boston, United States Health care, Biotech Channel Medsystems 1 74 11 19 •••@longwoodfund.com (617)3••• In the CSV
21 MP Healthcare Venture Management Corporate venture arm Boston, United States Biotech, Health care Draupnir Bio, Outrun TX, Covagen 46 4 10 •••@mp-healthcare.com 617-73•••
22 Iaso Ventures Venture capital firm Boston, United States Biotech, Artificial intelligence Prudentia Sciences 1 15 0 1 •••@iasoventures.com In the CSV
23 HarbourVest Partners Private equity firm Boston, United States Fintech, Hardware Varo Bank 1 273 52 147 •••@harbourvest.com +1 617••• In the CSV
24 Castor Ventures Venture capital firm Boston, United States Artificial intelligence, Health care Pie Systems, Sorcero 2 167 3 39 In the CSV
25 RockPort Capital Venture capital firm Boston, United States Hardware, Biotech NewLeaf Symbiotics, EcoFactor, Gazelle 108 25 26 415-78••• In the CSV
26 Glasswing Ventures Venture capital firm Boston, United States Artificial intelligence, Cybersecurity Enlaye, Lambent, Allure Security Technology 3 85 41 12 •••@glasswing.vc (617) ••• In the CSV
27 J2 Ventures Venture capital firm Boston, United States Artificial intelligence, Cybersecurity Cinder Technologies, Code Metal 2 49 20 0 In the CSV
28 Material Impact Venture capital firm Boston, United States Biotech, Hardware Actnano, Tierra Biosciences, Talus Renewables 45 22 3 In the CSV
29 Argon Ventures Venture capital firm Boston, United States Artificial intelligence, Biotech EnFi 1 42 9 4 In the CSV
30 Newpath Management Private equity firm, Venture capital firm Boston, United States Biotech, Health care Nvelop Therapeutics, Magnet Biomedicine 23 10 7 •••@newpath.partners In the CSV

Table 2. Biotech investors in Boston, Massachusetts: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 33.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 MassChallenge Boston, United States 26 325 HELIOS, DrizzleX, ScribeUp
2 RA Capital Management Boston, United States 9 47 Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics
3 Fidelity Boston, United States 7 40 Zipline International, Tenstorrent, SiMa.ai
4 MassVentures Boston, United States 6 35 Emvolon, ZwitterCo, Kytopen
5 Half Court Ventures Boston, United States 4 32 Light Frame, Flow Labs, Beacon Biosignals
6 Wellington Management Boston, United States 4 39 Tabby, Current, Element Biosciences
7 Cormorant Asset Management Boston, United States 4 13 Triveni Bio, Third Arc Bio, BlossomHill Therapeutics
8 Polaris Partners Boston, United States 3 73 Faro AI, Triveni Bio, Whisker Labs
9 Glasswing Ventures Boston, United States 3 24 Enlaye, Lambent, Allure Security Technology
10 PharmStars Boston, United States 2 12 Triomics, Medra AI
11 J2 Ventures Boston, United States 2 10 Cinder Technologies, Code Metal
12 NYBC Ventures Boston, United States 2 3 Vitestro, STRM.BIO
13 Pillar VC Boston, United States 2 24 Addis Energy, OpenHands
14 Castor Ventures Boston, United States 2 15 Pie Systems, Sorcero
15 Longwood Fund Boston, United States 1 4 Channel Medsystems

Table 3. Biotech investors in Boston, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Light Frame Light Frame builds core banking and portfolio management technology for wealth managers. Fintech Providence, United States Seed $5.1M 2026-11-10 $6.8M Half Court Ventures 1 to 10 2024
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management 11 to 50 2019
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity 1,001 to 5,000 2011
HELIOS HELIOS provides an AI-powered hockey platform that uses wearable sensors and video to measure player development. Artificial intelligence Portsmouth, United States Seed $1.1M 2026-11-03 $3.9M MassChallenge 11 to 50 2018
Emvolon Emvolon converts wasted resources into low-cost green fuels. Energy Woburn, United States Series A $22.0M 2026-10-27 $24.5M MassVentures 11 to 50 2021
DrizzleX DrizzleX addresses water waste in apartment buildings. Software Santa Fe Springs, United States Series A $6.8M 2026-10-20 $12.3M MassChallenge 11 to 50 2019
Tenstorrent Unicorn Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. Artificial intelligence Santa Clara, United States Series E $1.5B 2026-10-19 $2.5B Fidelity 501 to 1,000 2016
ScribeUp ScribeUp embeds subscription management into banking products for fintechs, banks, and credit unions. Commerce Los Angeles, United States Series A $10.0M 2026-10-19 $16.0M MassChallenge 11 to 50 2021
MuukTest MuukTest provides an AI-powered software testing platform that helps developers test their software faster. Artificial intelligence Raleigh, United States Seed $499K 2026-10-14 $7.0M MassChallenge 11 to 50 2019
SiMa.ai SiMa.ai develops hardware and software for deploying physical AI applications at the edge. Artificial intelligence San Jose, United States Series C $150.0M 2026-09-28 $505.0M Fidelity 101 to 250 2018

Table 4. Biotech investors in Boston, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 523 67%
Health care 275 35%
Artificial intelligence 214 27%
Biotech 183 23%
Hardware 127 16%
Fintech 90 11%
Commerce 68 9%
Education 35 4%
Cybersecurity 34 4%
Energy 24 3%

Table 5. Biotech investors in Boston, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in Boston, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 6 18%
2010s 13 39%
2000s 6 18%
1990s 4 12%
1980s 1 3%
1970s 1 3%

Table 7. Biotech investors in Boston, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Boston, Massachusetts are on the list?
33, in the file dated 16 November 2026. 24 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
22 of the 33 carry an email address in the download and 17 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 33 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 33 rows, 22 firm email addresses and 17 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 22 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Boston, Massachusetts: 33 rows, CSV, $29 one-time.

At once: the CSV with 33 rows, 22 firm email addresses and 17 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 12 of the 22 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in Boston

Other portfolio sectors in Boston

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 33 biotech investors in Boston, Massachusetts, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/boston-massachusetts/